AR054724A1 - Derivados benzamida inhibidores de la enzima histona desacetilasa (hdac) - Google Patents
Derivados benzamida inhibidores de la enzima histona desacetilasa (hdac)Info
- Publication number
- AR054724A1 AR054724A1 ARP060100215A ARP060100215A AR054724A1 AR 054724 A1 AR054724 A1 AR 054724A1 AR P060100215 A ARP060100215 A AR P060100215A AR P060100215 A ARP060100215 A AR P060100215A AR 054724 A1 AR054724 A1 AR 054724A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- 3alkyl
- amino
- alkoxy
- cycloalkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/73—Unsubstituted amino or imino radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/56—Amides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Procesos para su preparacion, composiciones farmacéuticas que los contienen y su uso en la fabricacion de un medicamento para su uso como agente antiproliferativo en la prevencion o el tratamiento de tumores u otros estados clínicos proliferativos sensibles a la inhibicion de histona deacetilasa (HDAC). Reivindicacion 1: Un compuesto caracterizado porque responde a la formula (1), donde: R1a se selecciona entre hidrogeno, amino, alquilo C1-3, N-alquilaminoC1-3, N,N-di-alquilaminoC1-3, o un grupo de subformula: R5R6N-X1-[CRaRb]q-, donde q es 1, 2 o 3; cada grupo Ra y Rb presente se selecciona en forma independiente entre hidrogeno, halo, hidroxi, o alquilo C1-4; X1 se selecciona entre un enlace directo o -C(O)-; y R5 y R6 se seleccionan en forma independiente entre sí, entre hidrogeno o alquilo C1-3; y donde si R1a es un grupo N-alquilaminoC1-3 o N,N- di-alquilaminoC1-3, la porcion alquilo C1-3 está opcionalmente sustituida con hidroxi o alcoxi C1-2; R1b se selecciona entre: i) hidrogeno, alquilo C1-6, halo-alquiloC1-6, hidroxi-alquiloC1-6, cicloalquilo C3-6, cicloalquilC3-6-alquiloC1-4, alcoxi C1-6, alcoxiC1-6-alquiloC1-6, N- alquilsulfamoiloC1-4; N,N-di(alquilC1-4)sulfamoilo; o ii) un grupo de subformula: R7R8N- [CRaRb]a-X2-, donde R7 y R8 se seleccionan en forma independiente entre hidrogeno, alquilo C1-6, cicloalquilo C3-6, cicloalquilC3-6-alquiloC1-6, alcoxiC1-6-alquiloC1-6, alquenilo C2-3, alquinilo C2-3, o un grupo de formula: R9R10N-[CRaRb]b-X3-, donde b es 1, 2, o 3; Ra y Rb tienen los valores que se han definido; X3 es un enlace directo o - C(O)-; R9 y R10 se seleccionan en forma independiente entre hidrogeno, alquilo C1-6, cicloalquilo C3-6, cicloalquilC3-6-alquiloC1-6, alcoxiC1-6- alquiloC1-6, o R9 y R10 están unidos de manera que, junto con el átomo de nitrogeno al cual están unidos, forman un anillo heterocíclico de 4, 5, 6 o 7 miembros, donde dicho anillo heterocíclico contiene opcionalmente, además del átomo de nitrogeno al cual R9 y R10 se unen, uno o más heteroátomos adicionales seleccionados entre N, O o S, y donde dicho anillo heterocíclico está opcionalmente sustituido con uno o más hidroxi, halo, alquilo C1-4, carbamoilo, oxo, -[CH2]e-NR11R12 (donde e es 0, 1 o 2, y R11 y R12 se seleccionan en forma independiente entre hidrogeno, alquilo C1-6, cicloalquilo C3-6 o cicloalquilC3-6-alquiloC1-6; o R7 y R8 están unidos de manera que, junto con el átomo de nitrogeno al cual están unidos, forman un anillo heterocíclico de 4, 5, 6 o 7 miembros, donde dicho anillo heterocíclico contiene opcionalmente, además del átomo de nitrogeno al cual R7 y R8 se unen, uno o más heteroátomos adicionales seleccionados entre N, O o S, y donde dicho anillo heterocíclico está opcionalmente sustituido con uno o más hidroxi, halo, alquilo C1-4, carbamoilo, oxo, alquenilo C2-4, alquinilo C2-4, alcoxi C1-4, alcoxiC1-4-alquiloC1-4, alquilC1-4-S(O)q- (donde q es 0, 1 o 2), un anillo heterocíclico de 5 o 6 miembros que comprende entre uno y tres heteroátomos seleccionados entre N, O o S o -[CH2]f-NR13R14 (donde f es 0, 1 o 2, y R13 y R14 se seleccionan en forma independiente entre hidrogeno, alquilo C1-6, cicloalquilo C3-6 o cicloalquilC3-6-alquiloC1- 6); X2 se selecciona entre un enlace directo, -O- o -C(O)-, con la condicion de que X2 solo puede ser -C(O)- si al menos uno de R7 o R8 es un grupo de formula: R9R10N-[CRaRb]b-X3-, como se ha definido; a es 0, 1, 2, 3 o 4; Ra y Rb tienen los valores que se han definido; o iii) un grupo de subformula: Q-Z-Y-, donde: Y es un enlace directo o -[CRaRb]x-, donde el entero x es entre 1 y 4 y Ra y Rb tienen los valores que se han definido; Z está ausente o se selecciona entre -O-, -S-, -SO-, SO2-, -NH- SO2-; -SO2-NH- o -C(O)-; y Q es un grupo heterociclilo unido mediante carbono o heterociclil-alquiloC1-6, donde dicho heterociclilo o heterociclil-alquiloC1-6 está opcionalmente sustituido sobre el anillo heterociclilo con uno o más grupos sustituyentes (por ejemplo 1, 2 o 3), que pueden ser iguales o diferentes, seleccionados entre halo, oxo, ciano, hidroxi, trifluorometilo, amino, carboxi, carbamoilo, mercapto, sulfamoilo, alquilo C1-3, alquenilo C2-3, alquinilo C2-3, alcoxi C1-3, alcanoilo C1-3, alcanoiloxi C1-3, alcoxiC1-3-alquiloC1-3, alcoxicarbonilo C1-3, halo- alquiloC1-3, N-(alquilC1-3)amino; N,N-di-(alquilC1-3)amino, N-(alcoxiC1-3-alquilC1-3)amino, N,N-di-(alcoxiC1-3-alquilC1-3)amino; N-(alcoxiC1-3-alquilC1-3)-N- (alquilC1-3)amino, N-alquilcarbamoiloC1-3, N,N-di-(alquilC1-3)carbamoilo, alquiltio C1-3, alquilsulfinilo C1-3, alquilsulfonilo C1-3, N-alquilsulfamoiloC1-3, N,N-di-(alquilC1-3)sulfamoilo; R1c se selecciona entre hidrogeno, halo, ciano, hidroxi, trifluorometilo, trifluorometoxi, amino, carboxi, carbamoilo, mercapto, sulfamoilo, alquilo C1-3, alquenilo C2-3, alquinilo C2-3, alcoxi C1-3, alcanoilo C1-3, alcanoiloxi C1-3, N-alquilaminoC1-3, N,N-di-(alquilC1-3)amino, alcanoilamino C1-3, N- alquilcarbamoiloC1-3, N,N-di- alquilcarbamoiloC1-3, alquiltio C1-3, alquilsulfinilo C1-3, alquilsulfonilo C1-3, alcoxicarbonilo C1-3, N-alquilsulfamoiloC1-3, y N,N-di- alquilsulfamoiloC1-3; el entero m es 0, 1, 2, 3 o 4; R2 es halo; el entero n es 0, 1, 2, 3, o 4; R3 se selecciona entre halo, ciano, hidroxi, trifluorometilo, trifluorometoxi, amino, carboxi, carbamoilo, mercapto, sulfamoilo, alquilo C1-3, alquenilo C2-3, alquinilo C2-3, alcoxi C1-3, alcanoilo C1-3, alcanoiloxi C1-3, N- alquilaminoC1-3, N,N-di-(alquilC1-3)amino, alcanoilamino C1-3, N-alquilcarbamoiloC1-3, N,N-di- alquilcarbamoiloC1-3, alquiltio C1-3, alquilsulfinilo C1-3, alquilsulfonilo C1-3, alcoxicarbonilo C1-3, N-alquilsulfamoiloC1-3, y N,N-di- alquilsulfamoiloC1- 3; R4 es amino o hidroxi; y W es metilo o etilo; o una sal aceptable para uso farmacéutico o prodroga del mismo.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0501146.5A GB0501146D0 (en) | 2005-01-20 | 2005-01-20 | Novel benzamide derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
AR054724A1 true AR054724A1 (es) | 2007-07-11 |
Family
ID=34224871
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP060100215A AR054724A1 (es) | 2005-01-20 | 2006-01-20 | Derivados benzamida inhibidores de la enzima histona desacetilasa (hdac) |
Country Status (6)
Country | Link |
---|---|
US (1) | US20080119451A1 (es) |
AR (1) | AR054724A1 (es) |
GB (1) | GB0501146D0 (es) |
TW (1) | TW200637823A (es) |
UY (1) | UY29340A1 (es) |
WO (1) | WO2006077387A2 (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0521244D0 (en) | 2005-10-19 | 2005-11-30 | Astrazeneca Ab | Benzamide compounds |
GB0526351D0 (en) * | 2005-12-23 | 2006-02-01 | Astrazeneca Ab | Novel benzamide derivatives |
TW200740769A (en) | 2006-03-16 | 2007-11-01 | Astrazeneca Ab | Novel process |
CN102295606A (zh) | 2006-05-29 | 2011-12-28 | 高点制药有限责任公司 | 合成3-(1,3-苯并间二氧杂环戊烯-5-基)-6-(4-环丙基哌嗪-1-基)-哒嗪的方法及其适用的中间体 |
EP2014656A3 (en) | 2007-06-11 | 2011-08-24 | High Point Pharmaceuticals, LLC | New heteocyclic h3 antagonists |
CN111909053B (zh) * | 2020-08-06 | 2022-12-06 | 湖北省生物农药工程研究中心 | 基于二芳胺单元的酰胺类衍生物及其制备方法和应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2002327627B2 (en) * | 2001-09-14 | 2006-09-14 | Methylgene Inc. | Inhibitors of histone deacetylase |
TWI319387B (en) * | 2002-04-05 | 2010-01-11 | Astrazeneca Ab | Benzamide derivatives |
GB2406856B (en) * | 2003-10-07 | 2005-10-19 | Renovis Inc | Amide compounds as ion channel ligands and uses thereof |
AR050926A1 (es) * | 2004-09-03 | 2006-12-06 | Astrazeneca Ab | Derivados de benzamida como inhibidores de la histonadesacetilasa(hdac) |
-
2005
- 2005-01-20 GB GBGB0501146.5A patent/GB0501146D0/en not_active Ceased
-
2006
- 2006-01-17 WO PCT/GB2006/000134 patent/WO2006077387A2/en not_active Application Discontinuation
- 2006-01-17 US US11/814,340 patent/US20080119451A1/en not_active Abandoned
- 2006-01-19 UY UY29340A patent/UY29340A1/es not_active Application Discontinuation
- 2006-01-20 AR ARP060100215A patent/AR054724A1/es not_active Application Discontinuation
- 2006-01-20 TW TW095102264A patent/TW200637823A/zh unknown
Also Published As
Publication number | Publication date |
---|---|
GB0501146D0 (en) | 2005-02-23 |
WO2006077387A2 (en) | 2006-07-27 |
UY29340A1 (es) | 2006-08-31 |
TW200637823A (en) | 2006-11-01 |
US20080119451A1 (en) | 2008-05-22 |
WO2006077387A3 (en) | 2006-10-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200702498A1 (ru) | N-(пиридин-2-ил)сульфонамидные производные | |
AR063643A1 (es) | Compuestos quimicos derivados de quinolina, un metodo de preparacion y composiciones farmaceuticas | |
AR053683A1 (es) | Derivados de piperidina con actividad antibacteriana | |
AR040409A1 (es) | Inhibidores de histona desacetilasa | |
TW200744587A (en) | Azaindole derivatives exhibiting PGD2 receptor antagonism | |
AR054724A1 (es) | Derivados benzamida inhibidores de la enzima histona desacetilasa (hdac) | |
PE20140863A1 (es) | Compuestos de benceno sustituidos con arilo o heteroarilo | |
TW200734322A (en) | Indole derivatives exhibiting PGD2 receptor antagonism | |
AR039257A1 (es) | Derivados de benzamida | |
PE20090648A1 (es) | Compuestos para el tratamiento de la hepatitis c | |
AR074608A1 (es) | Derivados de 2-(piperidin-1-il)-4-heterociclil-tiazol-5-carboxilico para infecciones bacterianas | |
PE20091556A1 (es) | Derivado heterociclico fusionado y su uso | |
PE20061150A1 (es) | Derivados de n-(n-sulfonilaminoarilmetil)ciclopropanocarboxamida sustituidos como antagonistas del receptor vainilloide tipo 1 (vdr1) | |
AR054445A1 (es) | Formulaciones de un inhibidor de src/abl | |
ATE524476T1 (de) | Pyrazolopyrimidine als modulatoren von caseinkinase ii (ck2) | |
GT200900283A (es) | "terapia de combinación con un compuesto actuando como un inhibidor del receptor adp plaquetario". | |
RS52169B (en) | STABLE LAKVINIMOD PREPARATIONS | |
PE20090276A1 (es) | Compuestos derivados de imidazoquinolina como moduladores de tlr7 | |
PE20080093A1 (es) | Inhibidores de la replicacion del virus de la inmunodeficiencia humana | |
AR051405A1 (es) | Compuestos de 2-carboxamido(3-amino)tiofeno | |
AR057981A1 (es) | Compuesto de pirroloquinolin -4- ona, su uso para la preparacion de un medicamento, composicion farmaceutica que lo comprende y compuestos intermediarios pra su preparacion | |
RS54644B1 (en) | ABET ANTIBODY FORMULATION | |
AR046615A1 (es) | Pirrolidinas 3-(benzoil)-n-aciladas, como inhibidores de 11-beta-hsd1, utiles en el tratamiento de desordenes metabolicos | |
PE20060526A1 (es) | Compuestos triciclicos como antagonistas de mglur1 | |
MX2011012628A (es) | Derivados amino-propionicos sustituidos como inhibidores de neprilisina. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |